Potential Effects of Corticosteroids on Physiological Dead-Space Fraction in Acute Respiratory Distress Syndrome

References

1. 1.↵
   1. Bernard GR,
   2. Artigas A,
   3. Brigham KL,
   4. Carlet J,
   5. Falke K,
   6. Hudson L,
   7. et al

   . The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818–824.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Ware LB,
   2. Matthay MA

   . The acute respiratory distress syndrome. N Engl J Med 2000;342(18):1334–1349.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.
   1. Coffey RL,
   2. Albert RK,
   3. Robertson HT

   . Mechanisms of physiological dead space response to PEEP after acute oleic acid lung injury. J Appl Physiol 1983;55(5):1550–1557.

   OpenUrlAbstract/FREE Full Text
4. 4.
   1. Greene R,
   2. Zapol WM,
   3. Snider MT,
   4. Reid L,
   5. Snow R,
   6. O'Connell RS,
   7. Novelline RA

   . Early bedside detection of pulmonary vascular occlusion during acute respiratory failure. Am Rev Respir Dis 1981;124(5):593–601.

   OpenUrlPubMedWeb of Science
5. 5.↵
   1. Nuckton TJ,
   2. Alonso JA,
   3. Kallet RH,
   4. Daniel BM,
   5. Pittet JF,
   6. Eisner MD,
   7. Matthay MA

   . Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 2002;346(17):1281–1286.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Meduri GU,
   2. Belenchia JM,
   3. Estes RJ,
   4. Wunderink RG,
   5. el Torky M,
   6. Leeper KV Jr.

   . Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest 1991;100(4):943–952.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Steinberg KP,
   2. Hudson LD,
   3. Goodman RB,
   4. Hough CL,
   5. Lanken PN,
   6. Hyzy R,
   7. et al

   . National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome N Engl J Med 2006;354(16):1671–1684.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Cepkova M,
   2. Kapur V,
   3. Ren X,
   4. Quinn T,
   5. Zhuo H,
   6. Foster E,
   7. et al

   . Pulmonary dead space fraction and pulmonary artery systolic pressure as early predictors of clinical outcome in acute lung injury. Chest 2007;132(3):836–842.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Kallet RH,
   2. Alonso JA,
   3. Pittet JF,
   4. Matthay MA

   . Prognostic value of the pulmonary dead-space fraction during the first 6 days of acute respiratory distress syndrome. Respir Care 2004;49(9):1008–1014.

   OpenUrlAbstract/FREE Full Text
10. 10.
    1. Gattinoni L,
    2. Carlesso E,
    3. Cressoni M

    . Assessing gas exchange in acute lung injury/acute respiratory distress syndrome: diagnostic techniques and prognostic relevance. Curr Opin Crit Care 2011;17(1):18–23.

    OpenUrlPubMed
11. 11.↵
    1. Raurich JM,
    2. Vilar M,
    3. Colomar A,
    4. Ibáñez J,
    5. Ayestarán I,
    6. Pérez-Bárcena J,
    7. Llompart-Pou JA

    . Prognostic value of the pulmonary dead-space fraction during the early and intermediate phases of acute respiratory distress syndrome. Respir Care 2010;55(3):282–287.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Doyle RL,
    2. Szaflarski N,
    3. Modin GW,
    4. Wiener-Kronish JP,
    5. Matthay MA

    . Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995;152(6):1818–1824.

    OpenUrlPubMedWeb of Science
13. 13.↵
    1. Ware LB

    . Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med 2005;33(3 Suppl):S217–S222.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Monchi M,
    2. Bellenfant F,
    3. Cariou A,
    4. Joly LM,
    5. Thebert D,
    6. Laurent I,
    7. et al

    . Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 1998;158(4):1076–1081.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.
    1. Cooke CR,
    2. Kahn JM,
    3. Caldwell E,
    4. Okamoto VN,
    5. Heckbert SR,
    6. Hudson LD,
    7. Rubenfeld GD

    . Predictors of hospital mortality in a population-based cohort of patients with acute lung injury. Crit Care Med 2008;36(5):1412–1420.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Seeley E,
    2. McAuley DF,
    3. Eisner M,
    4. Miletin M,
    5. Matthay MA,
    6. Kallet RH

    . Predictors of mortality in acute lung injury during the era of lung protective ventilation. Thorax 2008;63(11):994–998.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Spragg RG,
    2. Bernard GR,
    3. Checkley W,
    4. Curtis JR,
    5. Gajic O,
    6. Guyatt G,
    7. et al

    . Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med 2010;181(10):1121–1127.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Meduri GU,
    2. Headley AS,
    3. Golden E,
    4. Carson SJ,
    5. Umberger RA,
    6. Kelso T,
    7. Tolley EA

    . Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280(2):159–165.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Liu KD,
    2. Levitt J,
    3. Zhuo H,
    4. Kallet RH,
    5. Brady S,
    6. Steingrub J,
    7. et al

    . Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008;178(6):618–623.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Kallet RH,
    2. Jasmer RM,
    3. Pittet JF

    . Alveolar dead-space response to activated protein C in acute respiratory distress syndrome. Respir Care 2010;55(5):617–622.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Tobin MJ

    1. Rossi A,
    2. Polese G,
    3. Milic-Emili J

    . Monitoring respiratory mechanics in ventilator-dependent patients. In: Tobin MJ editor. Principles and practice of intensive care monitoring. New York: McGraw-Hill; 1998:553–596.
22. 22.↵
    1. Crossman PF,
    2. Bushnell LS,
    3. Hedley-Whyte J

    . Dead space during artificial ventilation: gas compression and mechanical dead space. J Appl Physiol 1970;28(1):94–97.

    OpenUrlFREE Full Text
23. 23.↵
    1. Forbat AF,
    2. Her C

    . Correction for gas compression in mechanical ventilators. Anesth Analg 1980;59(7):488–493.

    OpenUrlPubMedWeb of Science
24. 24.↵
    1. Enghoff H

    . Volumen inefficax: Bemerkungen zur Frage des schädlichen Raumes. Upsala Lakareforen Forh 1938;44:191–218. Article in German.

    OpenUrl
25. 25.↵
    1. Le Gall Jr.,
    2. Lemeshow S,
    3. Saulnier F

    . A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270(24):2957–2963.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Vincent JL,
    2. Moreno R,
    3. Takala J,
    4. Willatts S,
    5. De Mendonça A,
    6. Bruining H,
    7. et al

    . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22(7):707–710.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Murray JF,
    2. Matthay MA,
    3. Luce JM,
    4. Flick MR

    . An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138(3):720–723.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Tang BM,
    2. Craig JC,
    3. Eslick GD,
    4. Seppelt I,
    5. McLean AS

    . Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2009;37(5):1594–1603.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Sessler CN,
    2. Gay PC

    . Are corticosteroids useful in late-stage acute respiratory distress syndrome? Respir Care 2010;55(1):43–55.

    OpenUrlAbstract/FREE Full Text